Modern obstetrical and infertility care may increase the prevalence of disease: An evolutionary concept

Fertility and Sterility

Volumn 79, Issue 2, 2003, Pages 249-252

  Gleicher, Norbert ^a,b,c  

^a CENTER FOR HUMAN REPRODUCTION   (United States)

^b Chicago Center for Human Reproduction   (United States)

^c Foundation for Reproductive Medicine   (United States)

Author keywords

Autoimmune diseases; Diabetes mellitus; Evolution; Genetic risk

Indexed keywords

INSULIN;

AUTOIMMUNE DISEASE; CHROMOSOME DELETION Y; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE TRANSMISSION; EVOLUTION; FEMALE INFERTILITY; FETUS DEATH; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC RISK; HEALTH CARE; HUMAN; HYPOTHESIS; INHERITANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTRACYTOPLASMIC SPERM INJECTION; MALE INFERTILITY; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSTETRIC CARE; OVARY POLYCYSTIC DISEASE; PHYLOGENY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROGENY; REPRODUCTIVE SUCCESS; REVIEW; SPONTANEOUS ABORTION; TREATMENT OUTCOME;

EID: 0037309236     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04573-9     Document Type: Review

References (40)

1. Cooper D.S., DeAngelis C.D. Diabetes mellitus - a call for papers. JAMA. 786:2001;968-969.
2. Olefsky J.M. Prospects for research in diabetes mellitus. JAMA. 785:2000;628-632.
3. Aubert RE, Ballard DJ, Bennett PH, Barrett-Connor E, Geiss LS, Kenny SJ. Prevalence and incidence of non-insulin-dependent diabetes. Diabetes in America. 2nd ed. Collingdale, PA: Diane Publishing Company, 1996:47-62.
4. Dabelea D., Hanson R.L., Bennet P.H., Romain J., Knowler W.C., Pettitt D.J. Increasing prevalence of type II diabetes in American Indian children. Diabetologia. 41:1998;904-910.
5. Adler J, Kalb C. An American epidemic: diabetes. Newsweek 2000;September 4:40-7.
6. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, the American Diabetes Association: Alexandria, Virginia. Diabetes Care 1998;21(Suppl 1):s5-19.
7. American Diabetes Association. Screening for Type 2 diabetes idem. s20-2.
8. Newman B., Selby J.V., Slemenda C., Fabsitz R., Friedman G.D. Concordance for type 2 (non-insulin dependent) diabetes mellitus in male twins. Diabetologia. 30:1987;763-768.
9. Barnett A.H., Eff C., Leslie R.D.G., Pyke D.A. Diabetes in identical twins. Diabetologia. 20:1981;87-93.
10. Warram J.H., Krolewski A.S., Gottlieb M.S., Kahn C.R. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med. 311:1984;149-152.
11. Vadheim C.M., Rotter J.I., MacLaren N.K., Riley W.J., Anderson C.E. Preferential transmission of diabetic alleles within the HLA gene complex. N Engl J Med. 315:1986;1314-1318.
12. Kjaer K., Hagen C., Sahda S.H., Eshoj O. Infertility and pregnancy outcome in an unselected group of women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol. 166:1992;1412-1418.
13. Skipper D. Diabetes mellitus and pregnancy. A clinical and analytical study. Q J Med. 7:1933;353-380.
14. Bergquist N. The gonadal function in female diabetes. Acta Endocrinol. 19:(Suppl 19):1954;1-20.
15. Hare J.W., White P. Pregnancy in diabetes complicated by vascular disease. Diabetes. 26:1977;953-955.
16. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 21:(Suppl):1998;s23-31.
17. Cousins L. The California Diabetes and Pregnancy Program a statewide collaborative program for the preconception and prenatal care for diabetic women . Clin Obstet Gynecol. 5:1991;443-460.
18. Miodovnik M., Mimouni F., Siddiqi T.I., Tsang R.C. Periconceptional metabolic status and risk for spontaneous abortion in insulin-dependent diabetic pregnancies. Am J Perinatol. 5:1988;368-373.
19. Greene M.F. Prevention and diagnosis of congenital anomalies in diabetic pregnancy. Clin Perinatol. 20:1993;533-547.
20. Coustan D.R., Berkowitz R.L., Hobbins J.C. Tight metabolic control of overt diabetes in pregnancy. Am J Med. 68:1980;845-852.
21. Mokdad A.H., Serdula M.D., Dietz H., Bowman B.A., Marks J.S., Koplan J.B. The spread of the obesity epidemic in the United States 1991-1998. JAMA. 282:1999;1519-1522.
22. Must A., Spadano J., Coakley E.H., Field A.E., Colditz G., Dietz W.H. The disease burden associated with overweight and obesity. JAMA. 282:1999;1523-1529.
23. McKinlay J., Marceau L. US public health and the 21st century diabetes mellitus . Lancet. 356:2000;757-761.
24. Franks S. Polycystic ovary syndrome. N Engl J Med. 333:1995;853-861.
25. Dunaif A., Segal K.R., Futtenweit W., Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1989;1165-1174.
26. Shoham Z., Patel A., Jacobs H.S. Polycystic ovarian syndrome safety and effectiveness of stepwise and low-dose administration of purified follicle stimulating hormone . Fertil Steril. 55:1991;1051-1056.
27. Ehrmann D.A., Sturis J., Byrne M.M., Karrison T., Rosenfield R.L., Polonsky K.S. Insulin secretory defects in a polycystic ovary syndrome relationship to insulin sensitivity and family history of non-insulin dependent diabetes mellitus . J Clin Invest. 96:1995;520-527.
28. Perloff JK. Congenital heart disease. In: Gleicher N, ed. Principles and practice of medical therapy in pregnancy. 2nd ed. Appleton & Lange, 1985:788-94.
29. Elkayam U., Gleicher N. Cardiac problems in pregnancy. 1. Maternal aspects. JAMA. 251:1984;2837-2838.
30. Girardi S.K., Mielnik A., Schlegel P.N. Submicroscopic deletions in the Y chromosome of infertile men . Hum Reprod. 12:1997;1635-1641.
31. Palermo G., Joris H., Devroey P., Van Steirteghem A.C. Pregnancies after intracytoplasmic sperm injection of single spermatozoon into an oocyte. Lancet. 340:1992;17-18.
32. Does intracytoplasmic sperm injection (ICSI) carry inherent genetic risks? A Practice Committee report. 2000;ASRM, Birmingham, AL.
33. Nelson J.L., Koepsell T.D., Dugowson C.E., Voigt L.F., Daling J.R., Hansen J.A. Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum. 36:1993;7-14.
34. Hardy C.D., Palmer B.P., Morton S.J., Muir K.R., Powell R.J. Pregnancy outcome and family size in systemic lupus erythematosus a case-control study . Rheumatology. 38:1999;559-563.
35. Silman A.J., Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset a controlled study . Ann Rheum Dis. 47:1988;441-444.
36. Bussen S., Steck T., Dietl J. Increased prevalence of thyroid antibodies in euthryoid women with a history of recurrent in vitro fertilization failure. Hum Reprod. 15:2000;545-548.
37. Lockshin M.D., Druzin M.C., Goes S., Qamar T., Magid M.S., Jovanovic L., et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med. 313:1985;152-156.
38. Kutteh W.H., Rote N.J., Silver R. Antiphospholipid antibodies and reproduction; the antiphophospholipid antibody syndrome. Am J Reprod Immunol. 44:1999;133-152.
39. Gleicher N, Karande V. Evidence that the cell traffic of pregnancy may contribute to the risk of autoimmune diseases in offspring and their mothers. Submitted for publication. 2002.
40. Uramoto K.M., Michet C.H., Thumboo J., Sunku J., O'Fallon W.M., Gabriel S.E. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 42:1999;46-50.